If you're not immune to measles you can catch it just by going into a room up to 2 hours after an infected person has left it!
Vaccines are a key component of global health policy and are essential in the defence of the health of young children. Our research focuses on the development and evaluation of new and improved vaccines.
Events and Training
We are committed to providing high quality education and training, together with research updates for medical professionals and all those involved in the area of vaccines and paediatric and adult infectious diseases.
There are a number of ways in which you can get involved in our research, inform our research and find out more about our work. To find out more about any of these options, follow the link below.
5 December 2019
A large field study of typhoid conjugate vaccine (TCV) in Nepal has shown a single dose to be safe and effective in reducing typhoid in children aged 9 months to <16 years in an endemic setting.
14 November 2019
It’s very exciting to see that the Ad26.ZEBOV/MVA-BN-Filo Ebola vaccine schedule is being used in a large-scale study in the Democratic Republic of Congo. This is an important step towards having multiple vaccine strategies available to fight this dreadful illness, as is the recent application for marketing authorisation of this schedule by the European Medicines Agency.
7 November 2019
For most people living in the United States and Europe, typhoid is a distant memory, a ghost of a disease from another time. But typhoid never disappeared. For many people living in low- and middle-income countries, typhoid is endemic and an all too common risk faced predominately by children.
A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease
Shields AM. et al, (2020), Journal of Clinical Immunology
Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA)
Burton MJ. et al, (2019), Cochrane Database of Systematic Reviews
Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model.
Jin C. et al, (2019), PLoS Negl Trop Dis, 13
Antibody-Dependent Natural Killer Cell Activation after Ebola Vaccination.
Wagstaffe HR. et al, (2019), J Infect Dis
The Future of Vaccines for Tuberculosis.
Stockdale L. and Fletcher H., (2019), Clin Chest Med, 40, 849 - 856
Tuesday, 25 February 2020 to Wednesday, 26 February 2020, 9am - 4pm
Free 2-day Training Event for general practice nurses and health professionals new to immunisation practice who administer / promote / advise about vaccines in the Thames Valley. Funding for this event is from NHS England through Health Education England.
Thursday, 19 March 2020 @ Kassam Stadium Conference Centre, Grenoble Road, Oxford, OX4 4XP
The annual Immunisation Seminar will be held at the Kassam Stadium Conference Centre, Oxford. It provides the ideal opportunity for practitioners to update their current immunisation knowledge and to hear the latest news on the topic of vaccination.
Monday, 29 June 2020 to Wednesday, 01 July 2020 @ St Catherine's College, Manor Road, Oxford, OX1 3UJ
IIC - The ESPID-Oxford Course is a residential training course covering topics in paediatric infection for paediatric infectious diseases trainees and trainers, and for all those who manage children with infections. This will be the 18th edition of the course.